Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.


TSX:TH - Post by User

Comment by qwerty22on Aug 31, 2021 6:03pm
133 Views
Post# 33792199

RE:RE:RE:RE:RE:Message for Thtx

RE:RE:RE:RE:RE:Message for Thtx

You need to define successful. If successful is just maintaining a higher market cap then we part ways.

Everything they are doing around messaging the cancer program looks exactly how I would expect it to look given what other serious biotech do. That's the problem I have with you and Bucks. I don't know exactly what you want. You want them to put out a PR tomorrow saying we enrolled X patients in Aug? Nobody does that. Nobody serious gives any sort of ongoing updates to trials filled with fluff for retail consumption. The interim data readout is defined as that point when they have something meaningful to say. Anything before that is by definition fluff. You have a lot of belief in the power of fluff.


scarlet1967 wrote: Once you have learned everything you can from
the successful companies in the space then you use your creative mind exploring new strategies to make the business more lucrative so it is a learning never ending process/progress.
Sticking to failing strategies/old fashioned approaches aren't the road to success.

 

<< Previous
Bullboard Posts
Next >>